Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu

Alternatives · ranked for women

Alternatives to Bayan Health

People usually look past Bayan Health because it scores lowest on postpartum & breastfeeding guidance (15/100) in our rubric, and because advertises retatrutide, marketed as "GLP-3", as coming soon — a drug not approved for anything.

Where Bayan Health is strongest
True monthly cost — 82/100
Semaglutide
$129/mo
Tirzepatide
$149/mo
Coverage
Not published

Bayan Health lands at #218 on our ranking with a Metabolic-Fit Score of 37/100. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.

Our #1 pick for women

Ranked #1 · Grade A−

CoreAge Rx

One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.

Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
All 50 states
Brand-name
Compounded only

More alternatives, in ranking order

ShedRx

Ranked #13 · Grade C

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

  • serves all 50 states, where Bayan Health lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against Bayan Health's 37

SynergyRX

Ranked #14 · Grade C

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

  • serves all 50 states, where Bayan Health lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against Bayan Health's 37

Belle Health

Ranked #64 · Grade C

Flat-rate pricing with a real dietitian included ($119/mo semaglutide, from $175/mo tirzepatide) from a nine-year-old operator — carrying an open FDA warning letter over how it described its own compounded products.

  • $10/mo cheaper than Bayan Health
  • serves all 50 states, where Bayan Health lists Not published
  • scores 52/100 against Bayan Health's 37

Eden

Ranked #2 · Grade B+

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

  • serves all 50 states, where Bayan Health lists Not published
  • scores 89/100 against Bayan Health's 37

CareBareRX

Ranked #18 · Grade C

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

  • serves all 50 states, where Bayan Health lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 71/100 against Bayan Health's 37

Trimi Health

Ranked #10 · Grade B−

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

  • serves all 50 states, where Bayan Health lists Not published
  • scores 80/100 against Bayan Health's 37

Breeze Meds

Ranked #11 · Grade C

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

  • serves all 50 states, where Bayan Health lists Not published
  • scores 78/100 against Bayan Health's 37

Fresh Day Meds

Ranked #81 · Grade C

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in, and there's no postpartum or PCOS-specific content.

  • $30/mo cheaper than Bayan Health
  • serves all 50 states, where Bayan Health lists Not published
  • scores 50/100 against Bayan Health's 37

Mondae

Ranked #140 · Grade C

Mondae is the rare provider on this page that will tell you who compounds your medication, and then let you choose. Its configurator names six pharmacies — Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx — and you pick one before checkout, which is a level of supply-chain disclosure most of this category treats as a trade secret. The pricing is straightforward in the way that matters: $115 a month for compounded semaglutide and $145 for compounded tirzepatide, no membership fee on top, and fixed as you titrate, so the number you start at is the number you keep. That last point is worth more than the sticker, because dose-priced plans routinely double between a starting dose and a maintenance dose. Both figures were checked properly rather than copied: the treatment pages are a live configurator that ships a '$NNN' placeholder where the price belongs until the page's scripts run, then cross-checked against the homepage card and the structured data the page publishes — three sources, one number. The gaps are the ordinary ones. Clinicians come through a contracted network, Bask Telehealth LLC, and none is named individually; there are no labs in the plan; nothing on the site speaks to postpartum, breastfeeding or PCOS; and Mondae warns that formulations differ between its six pharmacies and 'may contain additional additives,' which is a fair question to put to whichever one you pick.

  • $14/mo cheaper than Bayan Health
  • serves all 50 states, where Bayan Health lists Not published
  • scores 46/100 against Bayan Health's 37

Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.

← All comparisons